About Cynaptec Pharmaceuticals
Cynaptec Pharmaceuticals is a private company based in Stuart, Florida, incorporated in 2025 in Delaware. It has reported $6,000,000 raised in one offering on Form D since April 2025. Its chief executive is Frederick Sancilio.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 11, 2025 | Apr 17, 2025 | $6,000,000of $26.0M target | 1 | $6.0M | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Cynaptec Pharmaceuticals's Form D filed Apr 17, 2025.
JS
Jonah Shacknai
Director
CI
Charles Goulburn II
Director
WR
Wesley Ramjeet
Director
FS
Frederick Sancilio
Chief Executive Officer and director
SR
Seth Rodner
Director